UPMC joins investment round for Werewolf Therapeutics

November 24, 2019

Biotech startup secures $56 million Series A for advancement of cancer treatment

Read more here

You Might Also Like…

more from the newsletter
A Targeted Approach: Translational Sciences Invests in Mozart Therapeutics

April 2024

A Targeted Approach: Translational Sciences Invests in Mozart Therapeutics

Read More
Congratulations ACES 2024 Winner – John Lowman!

Congratulations ACES 2024 Winner – John Lowman!

Read More
Realyze Intelligence Joins Inaugural Class of CancerX Startup Accelerator

April 2024

Realyze Intelligence Joins Inaugural Class of CancerX Startup Accelerator

Read More